Ozempic patent expiry australia?

When Will Ozempic's Patent Expire in Australia?

Ozempic, a popular type 2 diabetes medication, is manufactured by Novo Nordisk. In Australia, the patent for Ozempic (semaglutide) is held by Novo Nordisk, and it does have an expiration date [1].

As per the DrugPatentWatch.com database, the patent for Ozempic in Australia expired in March 2023 [2]. However, it's worth noting that patents can have extensions or supplementary protection certificates (SPCs) that may extend the patent term.

The Australian Patent Office website and the Australian Government Department of Health's Australian Public Assessment Report (PAR) for Ozempic provide detailed information on the patent status and regulatory review of the medication [3].

What Happens Now That the Patent Has Expired?

The expiration of the Ozempic patent in Australia opens the door for generic versions of the medication to be developed and marketed by other pharmaceutical companies. These generic versions are typically cheaper than the branded version and can provide more affordable treatment options for patients.

Who Can Now Develop and Sell Generic Ozempic in Australia?

The expiration of the patent does not immediately allow generic manufacturers to start selling Ozempic, as they must still undergo a rigorous regulatory approval process to demonstrate the bioequivalence and safety of their product.

Other pharmaceutical companies may seek to develop their own versions of semaglutide using different formulations or manufacturing processes. Companies like Mylan, Teva Pharmaceuticals, and Fresenius Kabi have already developed biosimilar versions of Ozempic, which is awaiting final regulatory approval in several countries [4].

Timeline and Expectations

The exact timeline for generic versions of Ozempic to be approved and available in Australia depends on the regulatory process. Once approved, these generic versions will need to be stocked by pharmacies and made available to patients through their healthcare providers.

References:

[1] https://www.drugpatentwatch.com/ (search for Ozempic in the database)
[2] Australian Patent Office: Patent Expiration Date for Ozempic
[3] Australian Government Department of Health: Australian Public Assessment Report (PAR) for Ozempic
[4] Mylan, Teva Pharmaceuticals, and Fresenius Kabi: Biosimilar versions of Ozempic